{"id":"NCT03412890","sponsor":"Myovant Sciences GmbH","briefTitle":"LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids","officialTitle":"LIBERTY EXTENSION: An International Phase 3 Open-Label, Single-Arm, Long-Term Efficacy and Safety Extension Study to Evaluate Relugolix Co-Administered With Low-Dose Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-10-19","primaryCompletion":"2020-01-21","completion":"2021-01-13","firstPosted":"2018-01-29","resultsPosted":"2024-05-09","lastUpdate":"2024-05-09"},"enrollment":477,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Heavy Menstrual Bleeding","Uterine Fibroid"],"interventions":[{"type":"DRUG","name":"Relugolix","otherNames":["MVT-601","TAK-385"]},{"type":"DRUG","name":"Estradiol/norethindrone acetate","otherNames":["E2/NETA"]}],"arms":[{"label":"Relugolix plus E2/NETA","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to determine the long-term efficacy and safety of relugolix 40 milligrams (mg) once daily co-administered with estradiol (E2) and norethindrone acetate (NETA) for 28 weeks on heavy menstrual bleeding associated with uterine fibroids in participants who previously completed a 24-week treatment period in one of the pivotal studies (MVT-601-3001 or MVT-601-3002).","primaryOutcome":{"measure":"Percentage Of Participants Who Achieved Or Maintained An MBL Volume Of <80 Milliliters (mL) And At Least A 50% Reduction From Baseline MBL Volume At Week 52/End Of Treatment","timeFrame":"Week 52/End of Treatment","effectByArm":[{"arm":"Relugolix Plus E2/NETA (Group A)","deltaMin":86.5,"sd":null},{"arm":"Relugolix Plus Delayed E2/NETA (Group B)","deltaMin":79.87,"sd":null},{"arm":"Placebo (Group C)","deltaMin":75,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":150,"countries":["United States","Belgium","Brazil","Chile","Czechia","Hungary","Italy","Poland","South Africa"]},"refs":{"pmids":["37863160","37477173","36357960"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":163},"commonTop":["Headache","Nasopharyngitis","Hot flush","Hypertension"]}}